Generation of a new therapeutic d-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway
Abstract Acute myeloid leukemia (AML) is caused by clonal disorders of hematopoietic stem cells. Differentiation therapy is emerging as an important treatment modality for leukemia, given its less toxicity and wider applicable population, but the arsenal of differentiation-inducing agents is still v...
Main Authors: | Fei Yu, Yingshi Chen, Mo Zhou, Lingling Liu, Bingfeng Liu, Jun Liu, Ting Pan, Yuewen Luo, Xu Zhang, Hailan Ou, Wenjing Huang, Xi Lv, Zhihui Xi, Ruozhi Xiao, Wenyu Li, Lixue Cao, Xiancai Ma, Jingwen Zhang, Lijuan Lu, Hui Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-01-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-024-01822-w |
Similar Items
-
TLR8 agonist Motolimod-induced inflammatory death for treatment of acute myeloid leukemia
by: Wei Yang, et al.
Published: (2023-07-01) -
Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
by: Mani Ramzi, et al.
Published: (2018-07-01) -
SECONDARY CHRONIC MYELOID LEUKEMIA FOLLOWING RADIOACTIVE IODINE (I131)
by: Yousef Hailan, et al.
Published: (2021-11-01) -
A Rare B-Myeloid Conversion of Follicular Lymphoma into Clonally Related Acute Myeloid Leukemia: A Case Report
by: Xiyue Yan, et al.
Published: (2023-03-01) -
THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia
by: Lidan Zhu, et al.
Published: (2020-02-01)